v3.26.1
Accrued Expenses and Other Current Liabilities
 3 Months Ended
Jun. 30, 2026
Payables and Accruals [Abstract]  
Accrued Expenses and Other Current Liabilities Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consist of the following (in thousands):
June 30, 2026March 31, 2026
Research and development expenses$56,339 $33,860 
Contractual costs related to batoclimab program discontinuation42,482 42,482 
Accrued bonuses5,256 16,767 
Legal and other professional fees677 1,342 
Other expenses2,210 2,430 
Total accrued expenses and other current liabilities
$106,964 $96,881